Drugs and the renin-angiotensin system in covid-19.

Aronson, Jeffrey K; Ferner, Robin E

Aronson, Jeffrey K; Ferner, Robin E.

Aronson JK; Centre for Evidence-Based Medicine, Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, UK.
Ferner RE; Institute of Clinical Sciences, University of Birmingham, Birmingham, UK.

BMJ ; 369: m1313, 2020 Apr 02.

Article in English | MEDLINE | ID: covidwho-20232581

Subject(s)

Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Betacoronavirus/drug effects; Coronavirus Infections/drug therapy; Pneumonia, Viral/drug therapy; Angiotensin Receptor Antagonists/adverse effects; Angiotensin Receptor Antagonists/pharmacology; Angiotensin Receptor Antagonists/therapeutic use; Angiotensin-Converting Enzyme 2; Angiotensin-Converting Enzyme Inhibitors/adverse effects; Angiotensin-Converting Enzyme Inhibitors/pharmacology; Angiotensin-Converting Enzyme Inhibitors/therapeutic use; COVID-19; Coronavirus Infections/complications; Decision Making; Duration of Therapy; Humans; Hypertension/drug therapy; Pandemics; Peptidyl-Dipeptidase A/drug effects; Pneumonia, Viral/complications; Practice Guidelines as Topic; Renin-Angiotensin System/drug effects; Renin-Angiotensin System/physiology; SARS-CoV-2; COVID-19 Drug Treatment

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Pneumonia, Viral / Angiotensin-Converting Enzyme Inhibitors / Coronavirus Infections / Angiotensin Receptor Antagonists / Betacoronavirus Type of study: Prognostic study Topics: Long Covid Limits: Humans Language: English Journal: BMJ Journal subject: Medicine Year: 2020 Document Type: Article Affiliation country: Bmj.m1313

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google